Biotech and AI merge to develop disease fighting drugs
Wednesday, February 28th • Segment
An increasing number of large drug companies are building the technology into their businesses and research processes, sharing a conviction that AI’s recent advances, particularly in large generative models, will significantly accelerate drug development.
